rs41270321

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BA1BS2_Supporting

This summary comes from the ClinGen Evidence Repository: The c.1043A>C (NM_002185.5) variant in IL7R is a missense variant predicted to cause substitution of Asparagine by Threonine at amino acid 348 (p.Asn348Thr).The filtering allele frequency (the lower threshold of the 95% CI of 20801/1179968 alleles) of the c.1043A>C variant in IL7R is 0.01743 for European (non-Finnish) chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (>0.00566) for BA1, and therefore meets this criterion (BA1). Additionally, 215 adult homozygous occurrences are described in gnomAD (BS2_Supporting).In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: BA1 and BS2_Supporting. (VCEP specifications version 1) LINK:https://erepo.genome.network/evrepo/ui/classification/CA160111/MONDO:0012163/119

Frequency

Genomes: 𝑓 0.010 ( 20 hom., cov: 32)
Exomes 𝑓: 0.015 ( 195 hom. )

Consequence

IL7R
NM_002185.5 missense

Scores

18

Clinical Significance

Benign reviewed by expert panel B:7O:1

Conservation

PhyloP100: -2.30

Publications

12 publications found
Variant links:
Genes affected
IL7R (HGNC:6024): (interleukin 7 receptor) The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
IL7R Gene-Disease associations (from GenCC):
  • immunodeficiency 104
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • Omenn syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL7RNM_002185.5 linkc.1043A>C p.Asn348Thr missense_variant Exon 8 of 8 ENST00000303115.8 NP_002176.2 P16871-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL7RENST00000303115.8 linkc.1043A>C p.Asn348Thr missense_variant Exon 8 of 8 1 NM_002185.5 ENSP00000306157.3 P16871-1

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1550
AN:
152198
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00340
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00792
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0137
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0158
Gnomad OTH
AF:
0.00861
GnomAD2 exomes
AF:
0.0102
AC:
2571
AN:
251032
AF XY:
0.0100
show subpopulations
Gnomad AFR exome
AF:
0.00283
Gnomad AMR exome
AF:
0.00608
Gnomad ASJ exome
AF:
0.00994
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0134
Gnomad NFE exome
AF:
0.0157
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.0151
AC:
22112
AN:
1461802
Hom.:
195
Cov.:
32
AF XY:
0.0146
AC XY:
10606
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.00269
AC:
90
AN:
33480
American (AMR)
AF:
0.00633
AC:
283
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00884
AC:
231
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00263
AC:
227
AN:
86256
European-Finnish (FIN)
AF:
0.0128
AC:
685
AN:
53406
Middle Eastern (MID)
AF:
0.00659
AC:
38
AN:
5768
European-Non Finnish (NFE)
AF:
0.0177
AC:
19726
AN:
1111948
Other (OTH)
AF:
0.0138
AC:
831
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1258
2516
3774
5032
6290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
766
1532
2298
3064
3830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1552
AN:
152316
Hom.:
20
Cov.:
32
AF XY:
0.00949
AC XY:
707
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00339
AC:
141
AN:
41570
American (AMR)
AF:
0.00784
AC:
120
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4826
European-Finnish (FIN)
AF:
0.0137
AC:
145
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0158
AC:
1075
AN:
68020
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
77
154
232
309
386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0135
Hom.:
66
Bravo
AF:
0.00980
TwinsUK
AF:
0.0159
AC:
59
ALSPAC
AF:
0.0166
AC:
64
ESP6500AA
AF:
0.00363
AC:
16
ESP6500EA
AF:
0.0172
AC:
148
ExAC
AF:
0.0101
AC:
1224
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0155
EpiControl
AF:
0.0155

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Immunodeficiency 104 Benign:3
Apr 03, 2024
ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The c.1043A>C (NM_002185.5) variant in IL7R is a missense variant predicted to cause substitution of Asparagine by Threonine at amino acid 348 (p.Asn348Thr). The filtering allele frequency (the lower threshold of the 95% CI of 20801/1179968 alleles) of the c.1043A>C variant in IL7R is 0.01743 for European (non-Finnish) chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (>0.00566) for BA1, and therefore meets this criterion (BA1). Additionally, 215 adult homozygous occurrences are described in gnomAD (BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: BA1 and BS2_Supporting. (VCEP specifications version 1) -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.0010
DANN
Benign
0.22
DEOGEN2
Benign
0.11
T
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.19
T
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L
PhyloP100
-2.3
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.33
N
REVEL
Benign
0.029
Sift
Benign
0.78
T
Sift4G
Benign
0.80
T
Polyphen
0.0010
B
Vest4
0.052
MPC
0.015
ClinPred
0.000020
T
GERP RS
-9.9
Varity_R
0.027
gMVP
0.15
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41270321; hg19: chr5-35876251; COSMIC: COSV57414714; API